Literature DB >> 6159047

Does interferon cure cancer?

K Sikora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6159047      PMCID： PMC1714259          DOI： 10.1136/bmj.281.6244.855

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  18 in total

1.  Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells.

Authors:  K PAUCKER; K CANTELL; W HENLE
Journal:  Virology       Date:  1962-06       Impact factor: 3.616

2.  Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.

Authors:  T C Merigan; K Sikora; J H Breeden; R Levy; S A Rosenberg
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

Review 3.  Interferons: anti-neoplastic drugs?

Authors:  H Strander
Journal:  Blut       Date:  1977-09-18

4.  Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy.

Authors:  G S Gilchrist; J C Ivins; R E Ritts; D J Pritchard; W F Taylor; J M Edmonson
Journal:  Cancer Treat Rep       Date:  1978-02

Review 5.  Interferon: therapeutic fact or fiction for the '80s?

Authors:  G M Scott; D A Tyrrell
Journal:  Br Med J       Date:  1980-06-28

6.  Cancer chemotherapy--what have we achieved?

Authors:  R A Milsted; M H Tattersall; R M Fox; R L Woods
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

7.  Interferons and cancer.

Authors:  R M Friedman
Journal:  J Natl Cancer Inst       Date:  1978-06       Impact factor: 13.506

Review 8.  Anti-tumor effects of interferon and its possible use as an anti-neoplastic agent in man.

Authors:  H Strander
Journal:  Tex Rep Biol Med       Date:  1977

9.  Effect of injections of small doses of human fibroblast interferon into genital warts. A pilot study.

Authors:  G M Scott; G W Csonka
Journal:  Br J Vener Dis       Date:  1979-12

10.  Promethazine hydrochloride: use in patients with Rh isoimmunization.

Authors:  M A Stenchever
Journal:  Am J Obstet Gynecol       Date:  1978-03-15       Impact factor: 8.661
View more
  8 in total

1.  Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression.

Authors:  Yuliya V Katlinskaya; Kanstantsin V Katlinski; Qiujing Yu; Angelica Ortiz; Daniel P Beiting; Angela Brice; Diwakar Davar; Cindy Sanders; John M Kirkwood; Hallgeir Rui; Xiaowei Xu; Constantinos Koumenis; J Alan Diehl; Serge Y Fuchs
Journal:  Cell Rep       Date:  2016-03-24       Impact factor: 9.423

Review 2.  Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints.

Authors:  Diana Saleiro; Leonidas C Platanias
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

3.  What does "response" in cancer chemotherapy really mean?

Authors:  J V Watson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-04

4.  Interferon and cancer.

Authors:  K Sikora; H Smedley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-05

5.  Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice.

Authors:  Y Nosoh; T Toge; K Niimi; M Nishiyama; N Hirabayashi; K Nakanishi; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1987-05

6.  Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.

Authors:  K Funa; G V Alm; L Rönnblom; K Oberg
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

7.  Toxicity of interferon.

Authors:  G M Scott; D S Secher; D Flowers; J Bate; K Cantell; D A Tyrrell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-25

8.  A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer.

Authors:  Abdel Nasser Hosein; Julie Livingstone; Marguerite Buchanan; James F Reid; Michael Hallett; Mark Basik
Journal:  BMC Cancer       Date:  2015-03-15       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.